These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 10998138)
21. Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with an alopecia areata-like disease by targeting infiltrated lymphocytes. Tang L; Cao L; Bernardo O; Chen Y; Sundberg JP; Lui H; Chung S; Shapiro J J Invest Dermatol; 2003 Mar; 120(3):400-6. PubMed ID: 12603852 [TBL] [Abstract][Full Text] [Related]
22. Altered T cell subpopulations and serum anti-TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H/HeJ mouse model. Hashimoto K; Yamada Y; Fujikawa M; Sekiguchi K; Uratsuji H; Mori S; Watanabe H; Matsumoto T J Dermatol Sci; 2021 Oct; 104(1):21-29. PubMed ID: 34511266 [TBL] [Abstract][Full Text] [Related]
23. An unexpected twist in alopecia areata pathogenesis: are NK cells protective and CD49b+ T cells pathogenic? Kaufman G; d'Ovidio R; Kaldawy A; Assy B; Ullmann Y; Etzioni A; Paus R; Gilhar A Exp Dermatol; 2010 Aug; 19(8):e347-9. PubMed ID: 20653774 [TBL] [Abstract][Full Text] [Related]
24. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367 [TBL] [Abstract][Full Text] [Related]
25. The antiinflammatory effects of Xuefu Zhuyu decoction on C3H/HeJ mice with alopecia areata. He X; Duan X; Liu J; Sha X; Gong Y; Lu W; Li Z; Chen X; Li Y; Shen Z Phytomedicine; 2021 Jan; 81():153423. PubMed ID: 33310308 [TBL] [Abstract][Full Text] [Related]
26. Mitigation of delayed-type hypersensitivity reactions by a CD44 variant isoform v3-specific antibody: blockade of leukocyte egress. Seiter S; Engel P; Föhr N; Zöller M J Invest Dermatol; 1999 Jul; 113(1):11-21. PubMed ID: 10417612 [TBL] [Abstract][Full Text] [Related]
27. Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model. Wikramanayake TC; Villasante AC; Mauro LM; Perez CI; Schachner LA; Jimenez JJ Cell Stress Chaperones; 2012 Mar; 17(2):267-74. PubMed ID: 22042611 [TBL] [Abstract][Full Text] [Related]
28. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166 [TBL] [Abstract][Full Text] [Related]
29. Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ mice. Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Kissling S; Hummel S; Vitacolonna M; Kopp-Schneider A; Zöller M J Invest Dermatol; 2005 Nov; 125(5):945-51. PubMed ID: 16297194 [TBL] [Abstract][Full Text] [Related]
30. Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata. Zöller M; Freyschmidt-Paul P; Vitacolonna M; McElwee KJ; Hummel S; Hoffmann R Clin Exp Immunol; 2004 Mar; 135(3):398-408. PubMed ID: 15008971 [TBL] [Abstract][Full Text] [Related]
31. A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis. Alli R; Nguyen P; Boyd K; Sundberg JP; Geiger TL J Immunol; 2012 Jan; 188(1):477-86. PubMed ID: 22116824 [TBL] [Abstract][Full Text] [Related]
32. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study. Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507 [TBL] [Abstract][Full Text] [Related]
34. Abnormal interactions between perifollicular mast cells and CD8+ T-cells may contribute to the pathogenesis of alopecia areata. Bertolini M; Zilio F; Rossi A; Kleditzsch P; Emelianov VE; Gilhar A; Keren A; Meyer KC; Wang E; Funk W; McElwee K; Paus R PLoS One; 2014; 9(5):e94260. PubMed ID: 24832234 [TBL] [Abstract][Full Text] [Related]
35. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice. Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819 [TBL] [Abstract][Full Text] [Related]
37. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS J Invest Dermatol; 2001 Dec; 117(6):1357-62. PubMed ID: 11886495 [TBL] [Abstract][Full Text] [Related]
38. Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. Sundberg JP; Boggess D; Silva KA; McElwee KJ; King LE; Li R; Churchill G; Cox GA J Invest Dermatol; 2003 May; 120(5):771-5. PubMed ID: 12713579 [TBL] [Abstract][Full Text] [Related]
39. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Gilhar A; Kalish RS Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213 [TBL] [Abstract][Full Text] [Related]
40. Therapy for alopecia areata in mice using parathyroid hormone agonists and antagonists, linked to a collagen-binding domain. Katikaneni R; Gulati R; Suh D; Sakon J; Seymour A; Ponnapakkam T; Gensure R J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S61-2. PubMed ID: 24326563 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]